Private Equity
Heartland Ventures is seeking to raise $25 million for its maiden fund, according to an SEC filing. Based in South Bend, Indiana, Heartland Ventures invests in high-growth startups in the Midwest.
1 min read · 16 March 2018
Lundbeck has agreed to acquire Prexton Therapeutics for 100 million euros and will later pay up to 805 million euros in development and sales milestones. Based in The Netherlands and in Switzerland, Prexton is a biopharmaceutical company. Prexton's investors include Forbion, Seroba Life Sciences, Sunstone Capital and Ysios Capital.
4 min read · 16 March 2018
Nashville-based 180 Health Partners, which provides care coordination between opioid addicted mothers and healthcare providers, has raised $8 million in Series B financing. Spring Mountain Capital led the round with participation from Frist Cressey Ventures, Resolute Venture Partners and Altitude Ventures.
1 min read · 15 March 2018
Merchant Advance Capital, a Vancouver-based online small business finance firm, has closed a $30 million delayed draw term loan facility. The source of the funding was Comvest Credit Partners, the credit affiliate of Comvest Partners, a U.S. private equity and debt firm. The loan facility will be used by Merchant to refinance existing debt and for growth capital. Founded in 2010 by President and CEO David Gens, Merchant utilizes technology and data science to reduce risk and offer lower fees and flexible repayment schedules to small and medium-sized companies in Canada.
3 min read · 15 March 2018
3 min read · 15 March 2018
Hayward, California-based Arcus Biosciences, a developer of cancer immunotherapies, has raised $120 million for its IPO after pricing its 8 million shares at $15 per share. The stock began trading March 15, 2018 on the New York Stock Exchange under the ticker symbol "RCUS." Citigroup, Goldman Sachs and Leerink Partners are the lead underwriters. The investors included Taiho Ventures, GV, Invus, DROIA Oncology Ventures, Stanford University, The Column Group, Foresite Capital, Novartis and Celgene.
3 min read · 15 March 2018
3 min read · 15 March 2018
South San Francisco-based IDEAYA Biosciences Inc, an oncology-focused biotechnology company, has closed $94 million in financing. The investors included BVF Partners L.P., Perceptive Advisors LLC, Nextech Invest Ltd, GV, Roche Venture Fund, 6 Dimensions Capital, Boxer Capital of the Tavistock Group, Driehaus Capital Management, LLC, 5AM Ventures, Canaan Partners, Celgene Corporation, WuXi Healthcare Ventures and Alexandria Venture Investments.
1 min read · 15 March 2018
3 min read · 15 March 2018
SmartZyme BioPharma, a New York City-based life science startup, has raised an undisclosed amount of funding. OrbiMed Advisors and Virtus Inspire Ventures led the round. WallachBeth Capital was the placement agent.
1 min read · 14 March 2018
